POZ Community Forums

Meds, Mind, Body & Benefits => Research News & Studies => Topic started by: Ptrk3 on June 30, 2020, 07:46:13 pm

Title: Experimental Drug Ciapavir Spurs Reactivation of Latent HIV
Post by: Ptrk3 on June 30, 2020, 07:46:13 pm
From the June 30, 2020, edition of (online) POZ magazine, a quote:

“Ciapavir is the first Smac mimetic specifically optimized for an HIV cure, so it is significantly more potent for HIV than other molecules in this class,” said Nicholas Cosford, PhD, deputy director of the Cancer Center at Sanford Burnham Prebys and co–senior author of the study. “As a result, ciapavir may be effective when used on its own instead of in combination with a second drug, as our previous research showed, and potentially at lower doses.”

Link to story: